Angela Bagley
Chief Tech/Sci/R&D Officer bei TREVENA, INC.
Profil
Angela Bagley is currently the Vice President-Technical Operations at Trevena, Inc. Prior to her current position, she held the role of Global Head-Pharmaceutical at Bristol Myers Squibb Co. She also served as the VP-Global Supply Chain Planning & Logistics at Celgene Corp.
and as the Head-Supply Chain & Process Engineering at Merck & Co., Inc. Ms. Bagley completed her undergraduate degree at North Carolina State University.
Aktive Positionen von Angela Bagley
| Unternehmen | Position | Beginn |
|---|---|---|
| TREVENA, INC. | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Angela Bagley
| Unternehmen | Position | Ende |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| CELGENE | Corporate Officer/Principal | - |
Ausbildung von Angela Bagley
| North Carolina State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| TREVENA, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
